Programmed cell death 1‐expressing CD56‐negative natural killer (NK) cell expansion is a hallmark of chronic NK cell activation during dasatinib treatment

Dasatinib treatment markedly increases the number of large granular lymphocytes including natural killer (NK) cells in a proportion of Ph(+) leukemia patients, which associates with a better prognosis. In‐depth immune profiling of NK cells can predict therapeutic response in these patients. In the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiyama, Ken‐ichi, Kitawaki, Toshio, Otsuka, Yasuyuki, Takaori‐Kondo, Akifumi, Kadowaki, Norimitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893985/
https://www.ncbi.nlm.nih.gov/pubmed/33064914
http://dx.doi.org/10.1111/cas.14692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893985/
https://www.ncbi.nlm.nih.gov/pubmed/33064914
http://dx.doi.org/10.1111/cas.14692

Ejemplares similares